Clinical Trial Update: Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial investigating probucol-induced apoE to mitigate cognitive deterioration has completed Phase 1 and Phase 2 studies focused on dementia and age-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cognitive Decline
• Cognitive Impairment Due to Alzheimer Disease
• Dementia Due to Alzheimer Disease

Drugs mentioned

• Probucol-induced apoE (probucol-induced apoE)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Dementia of the Alzheimer Type, Age-related Cognitive Decline | Phase 1, Phase 2 | Status: COMPLETED